|Bid||21.19 x 800|
|Ask||21.75 x 1100|
|Day's range||21.11 - 21.25|
|52-week range||18.50 - 26.85|
|Beta (5Y monthly)||1.10|
|PE ratio (TTM)||1.57|
|Forward dividend & yield||1.16 (5.45%)|
|Ex-dividend date||01 Aug 2022|
|1y target est||N/A|
In a call with JPMorgan clients earlier this week, CEO Jamie Dimon offered his thoughts on everything from markets, to geopolitics, to competition, and teambuilding.
Yahoo Finance Editor-in-Chief Andy Serwer joins Yahoo Finance Live to share some of his biggest takeaways from JPMorgan CEO Jamie Dimon's presentation on a recent client call.
(Bloomberg) -- Taibang Biologic Group, a plasma-derived biopharmaceutical product maker, has chosen banks for an initial public offering in Hong Kong, according to people familiar with the matter.Most Read from BloombergThe Fed’s Damage to the Housing Market May Last YearsStriking Drop in Stress Hormone Predicts Long Covid in StudyTrump Calls for Release of Warrant Documents Used in SearchChina Has Painted Itself Into a Semiconductor CornerThree Days After Vote, Result Hangs in the Balance: Keny